Omicron COVID booster cuts hospitalization in over 65s, Israeli … – Reuters

JERUSALEM, Jan 9 (Reuters) – The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) sharply reduced hospitalizations among older patients, Israeli researchers said on Monday, in some of the first evidence of the jab's real-world effectiveness.The study by researchers from healthcare provider Clalit, Ben-Gurion University of the Negev and Sapir […]

Continue reading

COVID-19 vaccine for children after MIS-C appears safe – National Institutes of Health (.gov)

More »Search Health TopicsQuick LinksMore »Quick LinksMore »Quick LinksMore »Quick LinksMore »Quick LinksMore »Quick LinksNews ReleaseTuesday, January 3, 2023 NIH-supported study finds no serious complications following rare immune condition.A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis […]

Continue reading
1 46 47 48 49 50 90